MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
VIRX
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION

Viracta Therapeutics (VIRX) Ownership - Who owns Viracta Therapeutics?

Viracta Therapeutics Inc is a precision oncology company, focused on the development of new medicines targeting virus-associated malignancies... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
388.7K
P/E Ratio
N/A
Total Cash
N/A
Projected Growth
N/A
Total Debt
16.91M
Revenue
N/A
Risk (Beta)
2.32
Dividend Yield
N/A
Total Cash/Share
N/A
Total Debt/Equity
61.96
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
Ask AI
VS
Compare
VS
Compare
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for VIRX
A.I. Advisor
published General Information

General Information

a developer of oncology therapeutics for treatment of solid and hematologic cancers

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A
Who owns Viracta Therapeutics? VIRX symbol Ownership - Tickeron.com